Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2015

Feb 19, 2015

30339_dirs_2015-02-19_bab6c605-3d9a-4c29-8229-b088598de201.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2015-02-17

Reporting Person: Malone Daniel (Vice President & Controller)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-02-17 Common Stock A 1728.0000 $51.5300 Acquired 16026.3836 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 7.7578 Indirect
Common Stock 4204.4500 Indirect

Footnotes

F1: Bonus and incentive shares granted on 2/17/2015.

F2: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.